Select Page
Responsive Centered YouTube Video
Insight into medical response to COVID-19 in rural South Africa by Dr. Shankara Chetty
  • Dr. Chetty treated over 10,000 COVID-19 patients with zero deaths in a rural area. 1:23

  • Established a triage system with separate shelters for COVID-positive and suspected patients. 5:36

  • Focused on understanding the initial progression of the illness by physically examining every patient. 7:26

  • Addressed community fears by setting up a tent for in-person consultations during the pandemic. 7:44

Insights on establishing Doctors Federation for the World and addressing global health disparities
  • Doctors Federation for the World aims to address diseases globally with a scientific and ethical approach. 8:03

  • DFW focuses on inclusivity and equity in decision-making processes within healthcare. 12:49

  • Importance of understanding primary pathophysiology in diseases like hypertension, diabetes, and cancer. 13:27

  • Dr. Shankara Chetty successfully managed patients with breathlessness using antihistamines and steroids. 14:21

  • Patients presented with breathlessness on the eighth day, leading to a focus on understanding its pathophysiology. 15:01

Insight into immune response patterns in COVID-19 patients leading to sudden deterioration and effective treatment
  • Patients showed sudden onset of breathlessness on the eighth day, distinct from typical pneumonia progression. 15:35

  • Examined patients revealed lung restriction without wheezing or decreased airflow, indicating allergic reaction. 16:23

  • Severe allergic reactions led to patients requiring ventilators, while moderate cases progressed to long COVID. 17:29

  • Antihistamines were effective in treating the immune response on the eighth day, with immediate benefits when combined with steroids. 21:02

Insights on COVID-19 treatment and medical research challenges discussed by Dr. Shankara Chetty
  • Quick and aggressive treatment on a vital day can prevent downstream effects of COVID-19. 21:58

  • Inflammation sets in by day 11 and coagulation issues by day 14 if reaction persists. 22:25

  • Western-centric view on clinical trials contrasts with Eastern reliance on clinical acumen. 23:24

  • Medical journals not sole source of knowledge; need to listen to global information. 26:01

  • Discoveries should be quickly investigated, verified, and implemented based on patient outcomes. 27:20

  • Pathophysiology of illness should dictate interventions like ivermectin and hydroxychloroquine. 28:05

Discussion on the effectiveness of COVID-19 vaccines, treatment strategies, and concerns about mass vaccination
  • Dr. Chetty questioned the necessity of vaccines when effective treatment strategies could curb mortality and morbidity. 28:51

  • He highlighted the importance of understanding the immune response to COVID-19 and how it impacts treatment. 31:57

  • Dr. Chetty expressed concerns about the mass vaccination campaign without fully understanding the underlying mechanisms of immunity. 32:50

  • The narrative of no treatment options for COVID-19 needs to be addressed as there are safe and effective treatment strategies available. 34:34

  • He mentioned that vaccines may have helped in high-risk groups but raised issues about adverse events in individuals with certain health conditions. 34:51

  • Dr. Chetty emphasized the need to consider the risks and benefits of vaccination for individuals with pre-existing conditions. 35:09

Discussion on COVID-19 vaccination complications, funding influence on research, and need for reevaluation
  • Vaccine complications and autoimmune responses post-vaccination. 35:27

  • Funding and political agendas influencing scientific research priorities. 37:02

  • Concerns about spike protein as primary pathogen and allergen trigger. 38:00

  • Call for reevaluation and redirection of vaccine development strategies. 39:40

  • Lack of exploration on potential autoimmune diseases post-vaccination. 40:00

  • Importance of unbiased funding allocation for scientific progress. 41:19

  • Emphasis on prioritizing healthcare over pharmaceutical industry interests. 41:44

Insights on COVID-19 progression, vaccine impact, and data importance in patient monitoring
  • Vaccines influencing disease progression need further research. 44:03

  • Data collection in global clinical trials crucial for understanding vaccine impact. 45:46

  • Comparison of vaccinated and unvaccinated patients reveals differences in disease markers. 47:02

  • Changes in interleukin-6, CRP, and D-dimers observed in different COVID-19 waves and variants. 47:51

  • Omicron variants showing rise in interleukins, particularly in unvaccinated patients. 48:16

Importance of understanding vaccine side effects and immune response for effective treatment and future pandemic management
  • Patients, both vaccinated and unvaccinated, are showing high interleukin levels and clotting issues, requiring close monitoring and treatment. 48:31

  • Auto antibodies to ACE2 may be targeting macrophages and platelets, leading to immune response-related patterns in vaccinated patients. 49:40

  • Colchicine and aspirin combination therapy shows promise in reducing stacking and platelet involvement in vaccinated patients with clotting issues. 52:17

  • Failure to learn lessons from the COVID-19 pandemic may lead to challenges in managing future outbreaks like monkey pox and hepatitis. 53:27

  • Data sharing and open discussion are crucial in understanding the impact of vaccination on emerging diseases and addressing potential risks. 54:07

Discussion on global health crisis, immunity suppression, vaccine efficacy, and virus origin investigation
  • Need to address population-wide immunity suppression in highly vaccinated countries. 55:29

  • Importance of understanding re-emergence of latent viruses due to immune suppression. 55:36

  • Call for questioning the competence of global health organizations and individual players. 56:10

  • Concern over lack of clarity on the source of the virus two years into the pandemic. 57:39

  • Criticism on the slow adaptation of vaccines to new variants like omicron. 59:47

  • Emphasis on asking hard questions and challenging scientific processes for progress. 1:00:43

  • Collaborative global reflection needed to address past failures and shape a better future. 1:01:26

Reflections on global health governance and the need for a paradigm shift in healthcare
  • Global complacency with individual freedoms impacting governance and regulatory bodies. 1:01:53

  • Call to re-evaluate unelected and unrepresentative international regulatory authorities. 1:02:15

  • Importance of questioning the competence of global organizations and their accountability. 1:02:57

  • Discussion on the formation and influence of Doctors Federation for the World. 1:04:04

  • Emphasis on uniting all sides of the healthcare debate based on good science. 1:07:01

  • Highlighting the need for a holistic healthcare approach integrating traditional medicine. 1:08:06

  • Shift towards promoting good health over solely focusing on treating illnesses. 1:09:01

Importance of prioritizing patient needs and joining the Doctors Federation for the World
  • Prioritize benefiting the patient in front of you 1:09:07

  • Appreciation for Dr. Shankara’s eloquence in speaking 1:09:23

  • Encouragement to learn more about the movement 1:09:47

  • Join the Doctors Federation for the World 1:09:54

  • Bringing a different kind of health to the world 1:10:02

  • Change the future of healthcare 1:10:02

  • Acknowledgment of future conversations with Dr. Shankara 1:10:08

  • Gratitude for the insightful discussion 1:10:15